MYGN
MYGN
US62855J1043
Myriad Genetics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 824.500.000 837.600.000
1.6%
Cost of Revenue 247.900.000 252.200.000
1.7%
Gross Profit 576.600.000 585.400.000
1.5%
644.400.000 673.400.000
4.3%
Operating Income -67.800.000 -88.000.000
23.0%
Pretax Income -395.100.000 -123.500.000
219.9%
Net Income Common Stockholders -365.900.000 -127.300.000
187.4%
-- --
--
-- --
--
ende